RIPRETINIB DEMONSTRATES COMPARABLE EFFICACY AND FEWER SIDE EFFECTS COMPARED TO SUNITINIB IN PATIENTS WITH GIST PREVIOUSLY TREATED WITH IMATINIB

Press/Media

PeriodJan 24 2022

Media coverage

1

Media coverage

  • TitleRIPRETINIB DEMONSTRATES COMPARABLE EFFICACY AND FEWER SIDE EFFECTS COMPARED TO SUNITINIB IN PATIENTS WITH GIST PREVIOUSLY TREATED WITH IMATINIB
    Media name/outletStates News Service
    Country/TerritoryUnited States
    Date01/24/22
    PersonsMargaret von Mehren